Jinyu Bio-technology Co., Ltd. (SHA:600201)
China · Delayed Price · Currency is CNY 15.51
-0.27 (-1.71%)
At close: Feb 13, 2026
Jinyu Bio-technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 100.76 | 108.99 | 283.63 | 210.66 | 382.29 | 406.2 |
Depreciation & Amortization | 211.11 | 211.11 | 189.26 | 200.16 | 191.59 | 173.64 |
Other Amortization | 7.11 | 7.11 | 0.25 | 0.3 | 0.31 | 0.48 |
Loss (Gain) From Sale of Assets | -2.58 | -2.58 | 0.04 | 0.04 | 2.31 | -0.04 |
Asset Writedown & Restructuring Costs | 14.33 | 14.33 | 23.42 | 66.56 | 41.75 | 0.4 |
Loss (Gain) From Sale of Investments | 9.49 | 9.49 | 7.78 | 9.81 | -3.19 | -32.48 |
Stock-Based Compensation | -4.52 | -4.52 | 57.22 | - | - | - |
Provision & Write-off of Bad Debts | 30.11 | 30.11 | 23.27 | 1.55 | 0.97 | -0.95 |
Other Operating Activities | -41.87 | -30.44 | -27.27 | -26.54 | 4.86 | 32.7 |
Change in Accounts Receivable | 14.99 | 14.99 | -67.03 | -70.17 | -125.1 | -61.89 |
Change in Inventory | 14.25 | 14.25 | 8.54 | -20.54 | 25.86 | -112.15 |
Change in Accounts Payable | -83.78 | -83.78 | -70.18 | -29.58 | 4.67 | 278.58 |
Change in Other Net Operating Assets | - | - | - | - | 11.08 | 5.66 |
Operating Cash Flow | 269.9 | 289.55 | 414.83 | 344.65 | 533.08 | 699.61 |
Operating Cash Flow Growth | -18.38% | -30.20% | 20.36% | -35.35% | -23.80% | 72.64% |
Capital Expenditures | -83.03 | -89.67 | -273.17 | -190.11 | -372.68 | -228.32 |
Sale of Property, Plant & Equipment | 0.13 | 0.84 | 0.01 | 0.26 | 0.54 | 1.58 |
Cash Acquisitions | - | - | - | - | - | 0.77 |
Investment in Securities | -274.73 | -408.56 | -491.15 | 210.59 | -66.14 | -204.96 |
Other Investing Activities | 312.11 | 44.24 | 24.2 | 35.88 | 10.16 | 45.22 |
Investing Cash Flow | -45.52 | -453.15 | -740.11 | 176.62 | -548.12 | -385.7 |
Short-Term Debt Issued | - | 15 | - | 60 | - | - |
Total Debt Issued | 15 | 15 | - | 60 | - | - |
Short-Term Debt Repaid | - | - | -10 | - | - | - |
Long-Term Debt Repaid | - | -1.88 | -0.78 | -0.83 | -0.5 | -40.08 |
Total Debt Repaid | -1.88 | -1.88 | -10.78 | -0.83 | -0.5 | -40.08 |
Net Debt Issued (Repaid) | 13.12 | 13.12 | -10.78 | 59.18 | -0.5 | -40.08 |
Issuance of Common Stock | 6.15 | 6.15 | 185.03 | - | 13.12 | 91.67 |
Repurchase of Common Stock | -6.14 | -6.14 | - | -366.14 | -1.66 | - |
Common Dividends Paid | -34.84 | -89.37 | -66.81 | -124.38 | -134.23 | -67.11 |
Other Financing Activities | -214.98 | 0.99 | 3.94 | -5.96 | - | 36.47 |
Financing Cash Flow | -236.68 | -75.24 | 111.38 | -437.29 | -123.28 | 20.95 |
Foreign Exchange Rate Adjustments | -0.02 | 0 | -0 | 0.1 | -0.08 | -0.3 |
Net Cash Flow | -12.32 | -238.84 | -213.9 | 84.07 | -138.4 | 334.56 |
Free Cash Flow | 186.87 | 199.89 | 141.67 | 154.54 | 160.4 | 471.3 |
Free Cash Flow Growth | 26.12% | 41.09% | -8.33% | -3.65% | -65.97% | 381.49% |
Free Cash Flow Margin | 14.08% | 15.92% | 8.86% | 10.11% | 9.03% | 29.79% |
Free Cash Flow Per Share | 0.18 | 0.18 | 0.13 | 0.14 | 0.14 | 0.42 |
Cash Interest Paid | - | - | - | - | - | 0.97 |
Cash Income Tax Paid | 90.43 | 97.75 | 141.79 | 106.65 | 115.63 | 109.43 |
Levered Free Cash Flow | 131 | 264.88 | 281.55 | 138.84 | -136.56 | 237.15 |
Unlevered Free Cash Flow | 131.47 | 268.32 | 281.59 | 141.85 | -136.54 | 237.76 |
Change in Working Capital | -54.04 | -54.04 | -142.76 | -117.9 | -87.8 | 119.68 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.